Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial

BACKGROUND: Observational studies support a role for oral anticoagulation to reduce the risk of dementia in atrial fibrillation patients, but conclusive data are lacking. Since dabigatran offers a more stable anticoagulation, we hypothesized it would reduce cognitive decline when compared to warfari...

Descripción completa

Detalles Bibliográficos
Autores principales: Caramelli, Bruno, Yu, Pai Ching, Cardozo, Francisco A. M., Magalhães, Iuri R., Spera, Raphael R., Amado, Daniel K., Escalante-Rojas, Maria C., Gualandro, Danielle M., Calderaro, Daniela, Tavares, Caio A. M., Borges-Junior, Flavio A., Pastana, Adriana F., Matheus, Mariana G., Brucki, Sonia M. D., Rodrigues, Ana Carolina O., Nitrini, Ricardo, Caramelli, Paulo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598018/
https://www.ncbi.nlm.nih.gov/pubmed/36284318
http://dx.doi.org/10.1186/s12916-022-02563-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598018/
https://www.ncbi.nlm.nih.gov/pubmed/36284318
http://dx.doi.org/10.1186/s12916-022-02563-2

Ejemplares similares